M James Barrett's Net Worth

M James Barrett's net worth is estimated to be at least $57,365,033.08 as of 10/01/2022. CoreStreet's estimation of M James Barrett's net worth is based on their sale of stock and current holding of stock.

M James Barrett is Director at GlycoMimetics Inc. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,539 units of GLYC stock on 05/10/2018. Their biggest sale was on 11/27/2017 when they sold 569,620 units of Appian Corp stock for $11,101,893.80. They typically trade 2 times per year.

Total value of insider buys:
  • $35,999,920.00
Total value of insider sells:
  • $21,365,113.08
Most recent insider trade:
  • May 10, 2018

M James Barrett's Insider Trading History

GlycoMimetics IncTitleAmountPriceTypeTotal Value
May 10, 2018
Director9,539$17.81Sell$169,889.59
Jan. 15, 2014
Director1,000,000$8.00Buy$8,000,000.00
Appian CorpTitleAmountPriceTypeTotal Value
Nov. 27, 2017
Major Shareholder569,620$19.49Sell$11,101,893.80
Mersana Therapeutics IncTitleAmountPriceTypeTotal Value
July 3, 2017
Major Shareholder1,000,000$15.00Buy$15,000,000.00
Zosano Pharma CorpTitleAmountPriceTypeTotal Value
Aug. 29, 2016
Major Shareholder50,000$1.01Sell$50,500.00
Supernus Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Dec. 8, 2015
Director212,970$14.56Sell$3,100,843.20
Nov. 25, 2015
Director16,179$16.35Sell$264,526.65
Nov. 18, 2015
Director93,000$16.61Sell$1,544,730.00
Nov. 16, 2015
Director119,650$16.24Sell$1,943,116.00
June 17, 2015
Director111,881$16.39Sell$1,833,729.59
June 16, 2015
Director55,105$16.85Sell$928,519.25
Clovis Oncology IncTitleAmountPriceTypeTotal Value
May 15, 2015
Director2,424$92.43Sell$224,050.32
June 4, 2013
Director2,483$70.80Sell$175,796.40
TRACON Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Feb. 4, 2015
Major Shareholder500,000$10.00Buy$5,000,000.00
Catalyst Biosciences IncTitleAmountPriceTypeTotal Value
Nov. 21, 2013
major shareholder5,333$5.16Sell$27,518.28
Epizyme IncTitleAmountPriceTypeTotal Value
Nov. 15, 2013
major shareholder406,500$19.68Buy$7,999,920.00